As of 2025-05-18, the Fair Value of Vyne Therapeutics Inc (VYNE) is -13.09 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.22 USD, the upside of Vyne Therapeutics Inc is -1,173.33%.
With the market price of 1.22 USD and our fair value calculation, Vyne Therapeutics Inc (VYNE) is not a good investment. Investing in VYNE stocks now will result in a potential loss of 1,173.33%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -255.57 | -73.33 | -23.21 | -28.45 | -39.83 | -84.08 |
| YoY growth | -246.77% | 71.31% | 68.35% | -22.59% | -40.00% | -33.94% |
| Market Cap (mil) | 18.56 |
| P/E | |
| Forward P/E |
| EPS | -2.62 |
| Avg earnings growth rate | -33.94% |
| TTM earnings | -39.83 |